je.st
news
The Market For DNA-Sequencing-Based Down's Syndrome Tests Could Exceed $6 Billion
2014-02-28 20:33:02| Biotech - Topix.net
On Wednesday night the New England Journal of Medicine published a study showing that a new, DNA-sequencing based blood test provides a dramatic improvement in accuracy at screening for Down's syndrome and a second, related disease.
Tags: market
tests
billion
exceed
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||